Tenofovir Disoproxil Fumarate Lawsuits

HIV/AIDS Patients Exposed To Serious Kidney And Bone Damage

Tenofovir Disoproxil Fumarate, or TDF, is a drug manufactured by Gilead Sciences Inc. The drug was marketed to, and used by, patients with HIV/AIDS and also individuals who wanted to take such a drug as a preventive measure. It was sold under various names, including Viread, Truvada, Atripla, Complera and Stribild. Many of the individuals who took these drugs have suffered medical problems that they were not properly warned about. In addition, Gilead Sciences Inc. may have hidden the frequency of these side effects and delayed the release of a safer alternative in order to make more money off the sales of TDF.

At Holman Schiavone, LLC, our experienced trial lawyers have the skill and resources to take on the makers of dangerous drugs. Our attorneys are able to take on even the largest pharmaceutical companies in the fight to protect medical consumers. We can help you get the compensation you deserve for the harm you suffered due to TDF.

Physical Problems Tied To Tenofovir Disoproxil Fumarate

Patients who took Truvada or other brands of TDF have developed the following medical problems:

  • Chronic kidney disease
  • Severe renal deficiency
  • Fatal renal insufficiency
  • End stage renal disease
  • Loss of bone density
  • Low bone mineral density
  • Bone loss
  • Bone breaks or fractures
  • Bone necrosis
  • Tooth loss attributed to bone density disorder (only if also suffering other injuries)
  • Fanconi Syndrome
  • Osteomalacia (softening of the bones)
  • Osteoporosis with pathological fracture

Drug companies often have a financial incentive to hide the dangerous side effects of their products. They invest enormous amounts of money in developing a new drug. If the drug's side effects prove to be severe, the maker can stand to lose millions. Unfortunately, this can result in companies working to hide the dangers from patients.

Gilead knew that TDF posed a serious danger to kidney function very early on in the process. The evidence of bone density problems started to pile in shortly after. Despite this evidence, and knowledge that different treatment was likely safer and just as effective, Gilead continued to sell TDF for many years. Patients continued to be prescribed TDF drugs without being properly warned of the risks.

Contact Our Experienced Tenofovir Claims Attorneys Now

If you were given Truvada, Viread, Atripla, Complera or Stribild and have since suffered kidney or bone problems, you need to speak to one of our attorneys as soon as possible. Call 816-399-5149 or contact us online to schedule a free consultation. We can help you hold drug makers accountable for the harm they caused.